INS and polycystic ovary syndrome: Obese PCOS patients often display dyslipidemia—characterized by elevated triglycerides, increased LDL-C, and reduced HDL-C—driven by enhanced free fatty acid release from adipocytes, which impairs insulin signaling and promotes hepatic synthesis of triglycerides and very low-density lipoprotein [83].